Maybe the change of ownership in Kiwibank has rattled some sellers. Perhaps Kiwibank will not be under the same pressure to maintain profit margins?
Printable View
HGH is Jarden's brokers pick while Forbar says it will underperform with target and fair value of $ 1.85
Our expert thinks HGH is fairly valued at currently available data ...but that can change tomorrow
Normally HGH makes its biggest move after next years guidance in August as it adjusts to next year EPS .
So fingers crossed ...though divvy will support but next year outlook is more important for bigger SP move
https://www.nzx.com/announcements/397405
Trading halt
Placement of new shares ...W69 mentioned it ....was not happy with this outcome
Now we know why someone was a continuous supplier at 2.15 from last many days
Doing private placement on the day of results !!!
Dont know why u think $ 1.70 ...maybe a good deal ....doing now so they get divvy also !!!!
U had such praise for Jeff ...so he must be investor friendly ...can be a good deal from investor angle ...cheap rights ?
Heartland expects NPAT for FY2023 to be in the range of $109 million to $114 million, excluding any impacts of fair value changes on equity investments held.
This will be on increased equity so next year eps growth will be ....??? Maybe 17.5 cents ...W69 please help us